Overexpression of OAS1 is correlated with poor prognosis in pancreatic cancer
L Lu, H Wang, J Fang, J Zheng, B Liu, L Xia… - Frontiers in …, 2022 - frontiersin.org
Background OAS1 expression in pancreatic cancer has been confirmed by many studies.
However, the prognostic value and mechanism of OAS1 in pancreatic cancer have not been …
However, the prognostic value and mechanism of OAS1 in pancreatic cancer have not been …
Genome-scale CRISPR-Cas9 screening stratifies pancreatic cancer with distinct outcomes and immunotherapeutic efficacy
L Wang, D Fu, S Weng, H Xu, L Liu, C Guo, Y Ren… - Cellular …, 2023 - Elsevier
Pancreatic cancer (PC) was featured by dramatic heterogeneity and dismal outcomes. An
ideal classification strategy capable of achieving risk stratification and individualized …
ideal classification strategy capable of achieving risk stratification and individualized …
Oncolytic activity of wild-type Newcastle disease virus HK84 against hepatocellular carcinoma associated with activation of type I interferon signaling
L Chen, Y Niu, J Sun, H Lin, G Liang… - Journal of Clinical …, 2021 - pmc.ncbi.nlm.nih.gov
Background and Aims Hepatocellular carcinoma (HCC) is listed as one of the most common
causes of cancer-related death. Oncolytic therapy has become a promising treatment …
causes of cancer-related death. Oncolytic therapy has become a promising treatment …
BDNF Acts as a Prognostic Factor Associated with Tumor‐Infiltrating Th2 Cells in Pancreatic Adenocarcinoma
Y Zhu, C Zhang, D Zhao, W Li, Z Zhao, S Yao… - Disease …, 2021 - Wiley Online Library
Pancreatic adenocarcinoma (PAAD) is an extremely lethal disease worldwide. Brain‐
derived neurotrophic factor (BDNF) is a critical member of the neurotrophin polypeptide …
derived neurotrophic factor (BDNF) is a critical member of the neurotrophin polypeptide …
Construction of a five-gene prognostic model based on immune-related genes for the prediction of survival in pancreatic cancer
B Liu, T Fu, P He, C Du, K Xu - Bioscience Reports, 2021 - portlandpress.com
Purpose: To identify differentially expressed immune-related genes (DEIRGs) and construct
a model with survival-related DEIRGs for evaluating the prognosis of patients with …
a model with survival-related DEIRGs for evaluating the prognosis of patients with …
Prognostic values and clinical significance of S100 family member's individualized mRNA expression in pancreatic adenocarcinoma
X Li, N Qiu, Q Li - Frontiers in Genetics, 2021 - frontiersin.org
Objective: Pancreatic adenocarcinoma (PAAD) is a common malignant tumor worldwide.
S100 family (S100s) is wildly involved in regulating the occurrence, development, invasion …
S100 family (S100s) is wildly involved in regulating the occurrence, development, invasion …
Up-regulation of S100P predicts the poor long-term survival and construction of prognostic signature for survival and immunotherapy in patients with pancreatic cancer
W Zou, L Li, Z Wang, N Jiang, F Wang, M Hu… - Bioengineered, 2021 - Taylor & Francis
Pancreatic cancer is associated with a high mortality rate, and the prognosis is positively
related to immune status. In this study, we constructed a prognostic signature from survival …
related to immune status. In this study, we constructed a prognostic signature from survival …
Construction of immune-related gene pairs signature to predict the overall survival of multiple myeloma patients based on whole bone marrow gene expression …
F Jafari-Raddani, Z Davoodi-Moghaddam… - Molecular Genetics and …, 2024 - Springer
Multiple myeloma (MM) is a plasma cell dyscrasia that is characterized by the uncontrolled
proliferation of malignant PCs in the bone marrow. Due to immunotherapy, attention has …
proliferation of malignant PCs in the bone marrow. Due to immunotherapy, attention has …
Peptidase inhibitor 16 promotes proliferation of pancreatic ductal adenocarcinoma cells through OASL signaling
Q Chen, LY Jiang, C Cao, FY Liu, DR Li… - Molecular …, 2024 - Wiley Online Library
Pancreatic ductal adenocarcinoma (PDAC) is a highly invasive cancer with a poor prognosis
and a 5‐year survival rate of less than 11%. As a member of the CAP superfamily of …
and a 5‐year survival rate of less than 11%. As a member of the CAP superfamily of …
Gene Expression Profiling Regulated by lncRNA H19 Using Bioinformatic Analyses in Glioma Cell Lines
Y Chae, J Roh, M Im, W Jang, B Kim… - Cancer Genomics & …, 2024 - cgp.iiarjournals.org
Background/Aim: Glioma, the most common type of primary brain tumor, is characterized by
high malignancy, recurrence, and mortality. Long non-coding RNA (lncRNA) H19 is a …
high malignancy, recurrence, and mortality. Long non-coding RNA (lncRNA) H19 is a …